Picture EBD Group ChinaBio Partnerting Forum 2021 651x80
Document › Details

PerkinElmer, Inc.. (4/16/19). "Press Release: PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research". Waltham, MA.

Organisations Organisation PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
  Organisation 2 Accenture Life Sciences Practice
  Today Accenture Scientific Informatics Services
  Group Accenture (Group)
Products Product Signals™ for Translational cloud-based informatics platform
  Product 2 ChemDraw® software
Index term Index term Accenture–PerkinElmer: bioinformatics, 201904– collab product integration of PE informatics solutions into Accenture Life Sciences platform
Person Person Wang, David (PerkinElmer 201904 General Manager Informatics)

Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has joined Accenture’s open partner ecosystem, designed to help solution providers, software vendors and life sciences companies team more effectively to accelerate drug discovery and improve patient outcomes.

The ecosystem is an integral part of Accenture’s cloud-based informatics research platform focused on improving productivity, efficiency and innovation in the drug discovery process. Accenture is currently working with a select number of independent software vendors and organizations, including PerkinElmer, to integrate their technology and content into Accenture’s research platform.

Joining the ecosystem is in sync with PerkinElmer’s strategy to deliver advanced informatics solutions that empower researchers to more quickly and easily spotlight key findings amidst the ever-growing volume, types and complexity of scientific big data.

PerkinElmer is making its informatics solutions compatible with Accenture’s integrated ecosystem starting with the following: key functionality of electronic laboratory notebooks, which allow for effective organization and sharing of experimental data; TIBCO® Spotfire® software for data visualization in research and clinical analytics; and ChemDraw® software, a leading application for chemistry-based analytics and workflows. PerkinElmer Signals™ solutions, which provide advanced analytics for R&D such as lead discovery and translational medicine, are also planned to be available via the Accenture ecosystem in the future.

“Today’s pharmaceutical companies are dealing with tremendous silos of data that are hard to access, expensive to maintain and can create missed opportunities to connect insights that propel new patient therapies,” said David Wang, general manager of Informatics at PerkinElmer. “Forward-looking life science organizations are reimagining, streamlining and accelerating the power of their research organizations by digitizing and integrating their big data. This is the promise of informatics in the lab, and we are pleased to be the largest instrument and informatics solution provider to join the Accenture ecosystem to date.”

“As PerkinElmer is a leading provider of lab instrument and informatics solutions, we’re pleased to welcome the company to Accenture’s open partner ecosystem and to be working closely with them to integrate their capabilities into our cloud-based research platform,” said Joe Donahue, a managing director in Accenture’s Life Sciences practice. “Our clients will benefit from access to PerkinElmer’s solutions and we look forward to collaborating with them to help our mutual clients gain insights from data to drive scientific discovery—ultimately improving patient outcomes.”

PerkinElmer at Bio-IT World 2019

In addition to sharing this news at Bio-IT World Conference & Expo this week, PerkinElmer is also exhibiting its Signals solutions at the event, as well presenting the following sessions on Wednesday, April 17:

Leverage the Cancer Genome Atlas for Data Discovery in Oncology
Track 7; 12:00 p.m.
Location: Waterfront 1B/1C

Co-Presentation: Collaborating to Create a Better Screening Data Process
Track 10; 5:15 p.m. (with Albany Molecular Research, Inc.)
Location: Cityview 1

For more information on PerkinElmer and its informatics solutions, please click here or visit booth #440 at the Seaport World Trade Center in Boston, April 16-18.

About PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of 12,500 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $2.8 billion in 2018, serves customers in more than 150 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at


Media Contact:
Jennifer McNeil

Record changed: 2019-06-09


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

More documents for PerkinElmer (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture BIO Deutschland German Corona Special 2021 Digital 650x80px

» top